Galileo has developed a successful platform that delivers therapeutically-relevant monoclonal antibodies at numbers and success rates unseen in the industry.
Galileo develops cutting-edge therapies that harness the immune system towards cures for a number of unmet medical needs, including a variety of cancers.
Galileo Biotech is a multinational biopharmaceutical company developing new treatments for a variety of unmet medical needs, in particular numerous cancer types...
Our company uses an array of cutting-edge scientific approaches, that uniquely allow for disease to instruct us on relevant therapeutic targets. In addition, our distinctive methodologies...
Galileo is a vibrant, dynamic, and innovative company with a passion for developing treatments for catastrophic diseases. Defeating these diseases requires a diverse and skilled team...
